通化东宝：恩格列净上半年以及第三季度均销售情况良好

Core Viewpoint - Tonghua Dongbao (600867) reported strong sales performance for its drug, Englitazone, with over 100% year-on-year growth in sales for the first three quarters of the year [1] Group 1 - The company indicated that the sales situation for Englitazone was good in both the first half and the third quarter of the year [1] - The sales revenue for the first three quarters exceeded 100% growth compared to the previous year [1]